GPC2-CAR T cells tuned for low antigen density mediate potent

Por um escritor misterioso

Descrição

Pediatric cancers often mimic fetal tissues and express proteins normally silenced postnatally that could serve as immune targets. We developed T cell…
GPC2-CAR T cells tuned for low antigen density mediate potent
Cancers, Free Full-Text
GPC2-CAR T cells tuned for low antigen density mediate potent
Reprogramming T cell differentiation and exhaustion in CAR-T cell therapy, Journal of Hematology & Oncology
GPC2-CAR T cells tuned for low antigen density mediate potent
Development of GPC2-directed chimeric antigen receptors using mRNA for pediatric brain tumors
GPC2-CAR T cells tuned for low antigen density mediate potent
JCM, Free Full-Text
GPC2-CAR T cells tuned for low antigen density mediate potent
JCM, Free Full-Text
GPC2-CAR T cells tuned for low antigen density mediate potent
GD2-CART01 for Relapsed or Refractory High-Risk Neuroblastoma
GPC2-CAR T cells tuned for low antigen density mediate potent
Overcoming on-target, off-tumour toxicity of CAR T cell therapy for solid tumours
GPC2-CAR T cells tuned for low antigen density mediate potent
GPC2-CAR T cells tuned for low antigen density mediate potent activity against neuroblastoma without toxicity - ScienceDirect
GPC2-CAR T cells tuned for low antigen density mediate potent
BiCisCAR T cells targeting both GPC2 and CD276 show potent NB
GPC2-CAR T cells tuned for low antigen density mediate potent
Development of GPC2-directed chimeric antigen receptors using mRNA for pediatric brain tumors. - Abstract - Europe PMC
GPC2-CAR T cells tuned for low antigen density mediate potent
Strategies to enhance CAR-T persistence, Biomarker Research
GPC2-CAR T cells tuned for low antigen density mediate potent
Preclinical development of a chimeric antigen receptor T cell therapy targeting FGFR4 in rhabdomyosarcoma - ScienceDirect
de por adulto (o preço varia de acordo com o tamanho do grupo)